Host: Joseph Saseen, PharmD, BCPS, BCACP, CLS Guest: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Drs. Cheeley and Saseen will discuss the biological effects of OM-3s and their mechanisms of action and review all recent major clinical trials. Fa

Host: Diana Do, MD Guest: Nancy M. Holekamp, MD Guest: Carl Regillo, MD One of the biggest challenges with anti-VEGF therapy is the burden of continued and frequent treatment. Fortunately, new options are on the horizon in neovascular age-related

Host: Cassandra B. Donnelly, DO Guest: Charles P. Vega, MD Post-exposure influenza prophylaxis should be a top-of-mind discussion with patients receiving an influenza diagnosis. Unfortunately, it remains an underused means to reduce secondary infec

Host: Clete A. Kushida, MD, PhD Guest: Michael J. Thorpy, MD While gaps in care remain, the future is bright for patients with narcolepsy. Data from cutting-edge clinical trials were recently presented at 2021 Virtual Sleep, the 35th Annual Meeting

Host: Carl C. Awh, MD Guest: Peter A. Campochiaro, MD The quest for durable VEGF-suppression in neovascular AMD and diabetic macular edema has led to significant advances in the operating room for surgical retina specialists. What are these new met

Host: Ezra Cohen, MD Guest: Barbara Burtness, MD Head and neck squamous cell carcinomas (HNSCC) represent a significant healthcare burden due to associated morbidity and mortality. Most patients survive less than a year after diagnosis and report a

Host: Lee P. Shulman, MD, FACMG, FACOG Guest: Kenneth J. Moise, Jr., MD Guest: Christopher Robinson, MD Hemolytic disease of the fetus and newborn (HDFN) is a rare disease that occurs due to the incompatibility between fetal and maternal red cell

Guest: John Ryan, MD, MB, BCh, BAO, MRCPI, FACC, FAHA John Ryan, MD discusses screening protocols, diagnostic and treatment algorithms, clinical trial evidence, and the vital role of multidisciplinary teams for the management of patients with CTD-PAH

Guest: Garth W. Garrison, MD Guest: Prema Menon, MD, PhD The diagnosis and management of chronic cough can be challenging. In fact, only an estimated 50 percent of patients with chronic cough are accurately diagnosed. Recent advances in the underst

Host: Kristi K. Orbaugh, MSN, NP, AOCN® Guest: Val R. Adams, PharmD, FCCP, BCOP, FHOPA Guest: Theresa W. Gillespie, PhD, MA, RN, FAAN Endocrine therapy is currently the cornerstone of treatment for advanced hormone receptor–positive (HR+) breast